Showing results (2021-2030 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|November 2, 2012
Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's diseaseSusan DutyCNS Drugs|February 22, 2015
Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanismsLaure Rouch, Philippe Cestac, Olivier Hanon, et al.CNS Drugs|June 20, 2014
Natalizumab: risk stratification of individual patients with multiple sclerosisCarmen Tur, Xavier MontalbanCNS Drugs|February 14, 2015
Role of apomorphine in the treatment of Parkinson's diseaseAllison Boyle, William OndoCNS Drugs|August 2, 2020
Risk of Major Adverse Cardiovascular Events Associated with Concomitant Use of Antidepressants and Non-steroidal Anti-inflammatory Drugs: A Retrospective Cohort StudyHan Eol Jeong, In-Sun Oh, Woo Jung Kim, et al.CNS Drugs|October 5, 2012
Clobazam : in patients with Lennox-Gastaut syndromeLily P H Yang, Lesley J ScottCNS Drugs|November 8, 2022
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor FluctuationsQianqian Wei, Yuyan Tan, Pingyi Xu, et al.CNS Drugs|February 4, 2023
Rimegepant: A Review in the Acute Treatment and Preventive Treatment of MigraineHannah A BlairCNS Drugs|March 28, 2023
Sex Differences in Outcomes of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Preadmission Use of AntiplateletsRoberta Noseda, Federico Rea, Alberto Pagnamenta, et al.CNS Drugs|March 24, 2023
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I DisorderMatthew Harlin, Murat Yildirim, Pedro Such, et al.Pageof 211